AETHLON MEDICAL INC (AEMD) Stock Price, Quote, News and Summary
NASDAQ:AEMD - Nasdaq - US00808Y4061 - Common Stock
AEMD Quote and Key Statistics
AETHLON MEDICAL INC
NASDAQ:AEMD (1/17/2025, 8:00:00 PM)
After market: 0.67 +0.01 (+0.93%)0.6638
-0.05 (-7.1%)
AEMD Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -127.38% | ||
| ROE | -187.24% | ||
| Debt/Equity | 0 |
AEMD Performance and Technical Analysis
AEMD Ownership and Analysts
AEMD Latest News and Analysis
Curious about the stocks that are showing activity after the closing bell on Thursday?
Thursday's after hours session: top gainers and losers
These stocks are moving in today's pre-market session
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
These stocks are moving in today's after hours session
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.
Top movers in Tuesday's after hours session
These stocks are moving in today's after hours session
Why MicroStrategy Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket
Shares of MicroStrategy Incorporated (NASDAQ:MSTR) rose sharply in today's pre-market trading.
About AEMD
Company Profile
Aethlon Medical, Inc. is a medical technology company which focuses on developing products to diagnose and treat life and organ threatening diseases. The company is headquartered in San Diego, California and currently employs 14 full-time employees. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based technology. The Hemopurifier is a United States Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which exosomes have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption application related to the treatment of life-threatening viruses that are not addressed with approved therapies.
Company Info
AETHLON MEDICAL INC
11555 Sorrento Valley Road, Suite 203
San Diego CALIFORNIA 92123 US
CEO: Charles J. Fisher Jr
Employees: 14
Company Website: https://www.aethlonmedical.com/
Investor Relations: http://ir.aethlonmedical.com
Phone: 16199410360
AEMD Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 88.19 | 211.09B | ||
| ABT | ABBOTT LABORATORIES | 25.11 | 196.83B | ||
| SYK | STRYKER CORP | 32.94 | 146.17B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.81 | 145.41B | ||
| MDT | MEDTRONIC PLC | 16.78 | 112.94B | ||
| BDX | BECTON DICKINSON AND CO | 18.04 | 68.84B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.13 | 41.16B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.08 | 38.72B | ||
| RMD | RESMED INC | 28.92 | 35.20B | ||
| IDXX | IDEXX LABORATORIES INC | 38.29 | 34.33B | ||
| DXCM | DEXCOM INC | 49.64 | 32.96B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 19.55 | 24.25B |